Delivery Order SPE2DB22D3301-SPE2DB24FY0UC
Award Date 2/14/24
Potential Completion Date 2/15/24
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The $38,606.00 delivery order has a completion date of February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA to deliver pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $9,651.50 to provide RABAVERT rabies vaccine with diluents. This award is part of Amerisourcebergen's broader contract vehicle with DLA, an indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, to deliver a wide range of pharmaceutical products and medical supplies to DLA Troop...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. The contract has a potential value of $3,860.60 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,581.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of RABAVERT rabies vaccine with diluents. The delivery order has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,606,199 units of RABAVERT Rabies Vaccine with diluents. This $1,544.24 contract has a completion date of February 9, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor and no set-aside designation was used. This delivery order contract falls under a $999,999,999.00 indefinite...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The award, valued at $35,517.52, has an ultimate completion date of April 1, 2024. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The contract has a potential value of $16,995.36 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a $22,391.48 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of RABAVERT rabies vaccines and diluents. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,176,731 units of the RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $1,930.30 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp also holds an...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide RABAVERT rabies vaccine with diluents. The $19,303 contract has a completion date of March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025 to deliver a comprehensive range of pharmaceuticals and...